Seasonal influenza vaccine effectiveness in persons aged 15–64 years: A systematic review and meta-analysis
JP Martins, M Santos, A Martins, M Felgueiras… - Vaccines, 2023 - mdpi.com
Influenza is a respiratory disease caused by the influenza virus, which is highly
transmissible in humans. This paper presents a systematic review and meta-analysis of …
transmissible in humans. This paper presents a systematic review and meta-analysis of …
[HTML][HTML] Efficacy and effectiveness of influenza vaccination in healthy children. A review of current evidence
A Orrico-Sánchez, Á Valls-Arévalo… - … y microbiologia clinica …, 2023 - Elsevier
Influenza is common in healthy children and adolescents and is associated with a high rate
of hospitalization in this group, especially for those< 5 years. Although the WHO has …
of hospitalization in this group, especially for those< 5 years. Although the WHO has …
Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey
J Su, Z Jia, X Wang, F Qin, R Chen, Y Wu, B Lu… - BMC Infectious …, 2022 - Springer
Background Vaccination has been proven to be an effective approach against the
coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine the …
coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine the …
Recent advances in the influenza virus vaccine landscape: a comprehensive overview of technologies and trials
SUMMARY In the United Kingdom (UK) in 2022/23, influenza virus infections returned to the
levels recorded before the COVID-19 pandemic, exerting a substantial burden on an already …
levels recorded before the COVID-19 pandemic, exerting a substantial burden on an already …
Safety, immunogenicity, efficacy and effectiveness of inactivated influenza vaccines in healthy pregnant women and children under 5 years: an evidence-based …
Annual influenza vaccination is often recommended for pregnant women and young
children to reduce the risk of severe influenza. However, most studies investigating the …
children to reduce the risk of severe influenza. However, most studies investigating the …
Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial
Background Influenza is a cause of febrile acute respiratory infection (FARI) in India;
however, few influenza vaccine trials have been conducted in India. We assessed absolute …
however, few influenza vaccine trials have been conducted in India. We assessed absolute …
Effectiveness of influenza vaccines in the HIVE household cohort over 8 years: is there evidence of indirect protection?
RE Malosh, JG Petrie, A Callear… - Clinical Infectious …, 2021 - academic.oup.com
Background The evidence that influenza vaccination programs regularly provide protection
to unvaccinated individuals (ie, indirect effects) of a community is lacking. We sought to …
to unvaccinated individuals (ie, indirect effects) of a community is lacking. We sought to …
Quadrivalent influenza vaccine (Sinovac Biotech) for seasonal influenza prophylaxis
YY Tao, JX Li, YM Hu, YS Hu, G Zeng… - Expert Review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Quadrivalent Influenza Vaccine (Sinovac Biotech) is a quadrivalent
split-virion-inactivated influenza vaccine approved in China in June 2020 for individuals≥ 3 …
split-virion-inactivated influenza vaccine approved in China in June 2020 for individuals≥ 3 …
[HTML][HTML] Respiratory viruses associated with severe acute respiratory infection in children aged< 5 years at a tertiary care hospital in Delhi, India during 2013–15
S Aneja, V Singh, VV Narayan, M Gohain… - Journal of Global …, 2024 - pmc.ncbi.nlm.nih.gov
Background With the increased availability of licensed vaccines for respiratory viruses such
as severe acute respiratory syndrome coronavirus 2, respiratory syncytial virus (RSV), and …
as severe acute respiratory syndrome coronavirus 2, respiratory syncytial virus (RSV), and …
Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
S Dhooria, S Arora, S Chaudhary… - Indian Journal of …, 2023 - journals.lww.com
Methods: The study participants included patients who recovered after acute severe COVID-
19 and presented with CS-DPLA at two or six month follow up and control group (without CS …
19 and presented with CS-DPLA at two or six month follow up and control group (without CS …